Ligand · L0C
L0C · 4-{[2-(4-{[(4-fluorophenyl)carbonyl]amino}-1H-pyrazol-3-yl)-1H-benzimidazol-6-yl]methyl}morpholin-4-ium
L0C, 4-{[2-(4-{[(4-fluorophenyl)carbonyl]amino}-1H-pyrazol-3-yl)-1H-benzimidazol-6-yl]methyl}morpholin-4-ium (C22 H22 F N6 O2 +1, 421.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site…
- Component
- L0C
- Formula
- C22 H22 F N6 O2 +1
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
L0C in 2 structures; the first of them:
- 2W1C · Structure determination of Aurora Kinase in complex with inhibitor · L0C A1391 · binds ARG137, LEU139, LYS141, VAL147, ALA160, LYS162, LEU194, LEU210 and 7 more
- 2W1C · Structure determination of aurora kinase in complex with inhibitor · L0C A1391 · binds ARG137, LEU139, LYS141, VAL147, ALA160, LYS162, LEU194, LEU210 and 7 more
Residues it binds most
LEU 2, ALA 2, LYS 2, ARG 2, GLU 2, GLY 2, PRO 2, THR 2, TYR 2, VAL 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.